Medizinische Universität Graz - Research portal
Selected Publication:
SHR Neuro Cancer Cardio Lipid Metab Microb
Reiter, N; El-Shabrawi, L; Leinweber, B; Berghold, A; Aberer, E.
Calcinosis cutis Part II. Treatment options.
J AM ACAD DERMATOL. 2011; 65(1): 15-22.
Doi: 10.1016/j.jaad.2010.08.039
Web of Science
PubMed
FullText
FullText_MUG
- Leading authors Med Uni Graz
- Aberer Elisabeth
- Co-authors Med Uni Graz
- Berghold Andrea
- El-Shabrawi-Caelen Laila
- Leinweber Bernd
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Because calcinosis cutis is a rare syndrome, there is a notable lack of controlled clinical trials on its treatment. The efficacy of calcinosis treatment has only been reported in single cases or small case series. No treatment has been generally accepted as standard therapy, although various treatments have been reported to be beneficial, including warfarin, bisphosphonates, minocycline, ceftriaxone, diltiazem, aluminium hydroxide, probenecid, intralesional corticosteroids, intravenous immunoglobulin, curettage, surgical excision, carbon dioxide laser, and extracorporeal shock wave lithotripsy.
- Find related publications in this database (using NLM MeSH Indexing)
- Biopsy, Needle -
- Calcinosis - diagnosis
- Ceftriaxone - therapeutic use
- Combined Modality Therapy -
- Drug Therapy, Combination -
- Education, Medical, Continuing -
- Evidence-Based Medicine -
- Female -
- Humans -
- Immunoglobulins, Intravenous - therapeutic use
- Immunohistochemistry -
- Laser Therapy - methods
- Lasers, Gas - therapeutic use
- Male -
- Minocycline - therapeutic use
- Prognosis -
- Recurrence -
- Risk Assessment -
- Severity of Illness Index -
- Skin Diseases - diagnosis
- Treatment Outcome -
- Warfarin - therapeutic use
- Find related publications in this database (Keywords)
- calcinosis cutis
- evidence-based medicine levels
- review
- treatment